PCSK9 and Alzheimer disease: PCSK9, whose levels are increased in the CSF of AD patients [6], may represent an additional deleterious factor affecting brain cholesterol metabolism in astrocytes and neurons, as well as exacerbating Aβ-mediated neurotoxicity, as summarized in Figure 9.